Open Access Article
Zhenhai
Jing†
a,
Qing
Zhou†
b,
Yan
Wang
c,
Peng
Meng
d,
Yuting
Duan
*e and
Qing
Hong
*f
aOncology Department, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266032, Shandong, China
bHospital of Traditional Chinese Medicine of Liaocheng City, Oncology Department, Liaocheng 252000, Shandong, China
cQingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital) outpatient department, Qingdao 266000, Shandong, China
dYantai Hospital of Traditional Chinese Medicine, Oncology Department, Yantai 264001, Shandong, China
eThe First People's Hospital of Tai'an Traditional Chinese Medicine Department, Tai'an 271000, Shandong, China. E-mail: dr.syedluqmanali@gmail.com
fHematology Department, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao 266032, Shandong, China. E-mail: qdhongqing2014@gmail.com
First published on 6th November 2025
Retraction of ‘Identification of MIG7, TGM2, CXCL8, and PDGFC as key genes in colon cancer with a bioinformatics-driven strategy for multi-epitope vaccine design’ by Zhenhai Jing et al., Mol. Syst. Des. Eng., 2025, https://doi.org/10.1039/D5ME00104H.
Given the significance of these concerns, the Editor has lost confidence that this paper is reliable.
We have attempted to contact all authors regarding this retraction using the email details provided by the corresponding author at this stage, however we cannot confirm if they are genuine. Yuting Duan, Qing Zhou, Zhenhai Jing, Qing Hong, Yan Wang and Peng Meng have not agreed with the decision to retract.
Signed: Maria Southall, Executive Editor, Molecular Systems Design & Engineering
Date: 23rd October 2025
Footnote |
| † Co-first author. |
| This journal is © The Royal Society of Chemistry 2025 |